Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Georgia Experts Applaud House Study Committee’s Public Health Report and Urge Sustained Legislative Action For a Safer, Healthier Georgia - Georgia Budget and Policy Institute